Skip to main content

Table 1 Baseline characteristic of patients with CRC from Ruijin Hospital (N = 48)

From: Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer

Factors Cohort (N = 48)
Gender
 Male 29 (60%)
 Female 19 (40%)
Age
  < 60 y 15 (31%)
  > 60 y 33 (69%)
MS status
 MSI-H 17 (35%)
 MSS 31 (65%)
Tumor location
 Right 17 (35%)
 Left 31 (65%)
T stage
 T2 3 (6%)
 T3 23 (48%)
 T4 22 (46%)
N stage
 N0 36 (75%)
 N1-2 12 (25%)
M stage
 M0 40 (83%)
 M1 8 (17%)
Stage
 I 3 (6%)
 II 30 (63%)
 III 8 (17%)
 IV 7 (14%)
Vascular invasion
 positive 10 (21%)
 negative 38 (79%)